Amgen Group

Operating company

Total cases

Claimant-side

Respondent-side

Amgen Group has been party to 22 Unified Patent Court cases, 8 times as claimant and 14 times as respondent. The most recent on record is UPC CFI 2220/2025 at the Munich Central Division.

Adversary analytics require an account

Recent cases

Latest filings involving this group and its entities.

View all cases

2025-12-23UPC CFI 2220/2025Munich CD—Amgen Inc. v Sanofi-Aventis Deutschland GmbH
2025-12-23UPC CFI 2221/2025Munich CD—Amgen Inc. v Regeneron Pharmaceuticals Inc.
2025-07-14UPC CoA 641/2025Court of Appeal—Sanofi Biotechnology SAS v Amgen Inc.
2025-02-28UPC CFI 195/2025Dusseldorf LDWithdrawnSanofi Biotechnology SAS v Amgen Inc.
2025-01-21UPC APP 3053/2025Hamburg LD—Amgen GmbH v Alexion Pharmaceuticals, Inc.
2025-01-21UPC APP 3214/2025Munich CD—Name not displayed for GDPR reasons. Represented by Sture RYGAARD v Sanofi-Aventis Deutschland GmbH
2024-09-13UPC CoA 528/2024Court of AppealDismissedAmgen Inc. v Sanofi-Aventis Deutschland GmbH
2024-09-13UPC CoA 529/2024Court of AppealPatent maintainedAmgen Inc. v Regeneron Pharmaceuticals Inc.
2024-08-14UPC APP 47154/2024Munich CDProcedural onlyDehns v Amgen Inc.
2024-08-14UPC APP 47163/2024Munich CDProcedural onlyDehns v Amgen Inc.